Immunogenicity and Safety of Pandemic Influenza Vaccines in Adults Aged 18 - 49 Years Old

Conditions

• Influenza

Interventions

• BIOLOGICAL: GSK Biologicals' investigational vaccine GSK2590066A
• BIOLOGICAL: GSK Biologicals' investigational vaccine GSK2592984A
• BIOLOGICAL: GSK Biologicals' investigational vaccine GSK2340274A
• BIOLOGICAL: GSK Biologicals' investigational vaccine GSK2340273A
• OTHER: Placebo

Sponsor

GlaxoSmithKline